logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Hospital Clínic de Barcelona

+34932275400
marvives@clinic.cat
Source: Site record.
http://www.clinicbarcelona.org

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Hospital Clínic de Barcelona, located at Carrer de Villarroel, 170, 08036 Barcelona, Spain, is a renowned public university hospital founded on December 22, 1906. Functioning as a part of the Catalan Public Health Network and closely tied to the University of Barcelona Faculty of Medicine, it is widely celebrated for its equal commitments to top-tier patient healthcare, academic teaching, and medical research. As a leading hospital in Spain and one of the highest-ranked medical institutions globally, it operates 10 highly specialized clinical institutes, managing a broad public community patient base alongside highly complex tertiary healthcare for local and international patients.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Human-provided. Dermatologist
Source: Human-provided. Government hospital
Source: Trial-derived.
754Total Trials
Source: Trial-derived.
179Recruiting Trials
Source: Trial-derived.
349Active Trials
Source: Trial-derived.
305Completed Trials
Source: Trial-derived.
897Unique Conditions
Source: Trial-derived.
562Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (19)Source: Trial-derived. Multiple Myeloma (19)Source: Trial-derived. COVID-19 (16)Source: Trial-derived. Coronary Artery Disease (13)Source: Trial-derived. Acute Myeloid Leukemia (12)Source: Trial-derived. Chronic Lymphocytic Leukemia (12)Source: Trial-derived. Breast Neoplasms (10)Source: Trial-derived. Heart Failure (10)

Sponsors

Source: Trial-derived. Hospital Clinic of Barcelona (69)Source: Trial-derived. AbbVie (49)Source: Trial-derived. Boehringer Ingelheim (33)Source: Trial-derived. Pfizer (32)Source: Trial-derived. Hoffmann-La Roche (31)Source: Trial-derived. Merck Sharp & Dohme LLC (31)Source: Trial-derived. Eli Lilly and Company (29)Source: Trial-derived. Daiichi Sankyo (24)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Electronic data capture
Source: AI-inferred. Electronic source (eSource) system

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. MRI
Source: AI-inferred. Six-minute walk test
Source: AI-inferred. Echocardiography
Source: AI-inferred. Spirometry
Source: AI-inferred. PET-CT

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. ELISA / immunoassay

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)
Source: AI-inferred. Research / investigational-drug pharmacy handling
Source: AI-inferred. Refrigerated (2-8 °C)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Cardiac catheterisation or electrophysiology procedures
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Blood transfusion service
Source: AI-inferred. Liver biopsy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Electronic patient-reported outcome (ePRO) diary system
Source: AI-inferred. Intratumoral injection administration
Source: AI-inferred. Minimal residual disease (MRD) testing
Source: AI-inferred. APOE genotyping
Source: AI-inferred. Autologous haematopoietic stem cell transplantation
Source: AI-inferred. B-cell enumeration
Source: AI-inferred. Circulating tumour cell enumeration